Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | Y017208 | OT / LA |
no additional AE; received improperly stored PROQUAD since it "was stored in the refrigerator for months" instead of the freezer; This spontaneous report was received from a registered nurse referring to a 11-year-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included polio vaccine inact 3v (Vero) (IPOL) (lot# Y1A201M), diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) tetanus vaccine toxoid (BOOSTRIX) (lot# CX4HL), meningococcal vaccine A/C/Y/W conj (CRM197) (MENVEO) (lot# LN75D), and hepatitis B vaccine rHBsAg (yeast) (ENGERIX B) (lot# 998J9). On 01-OCT-2024, the facility received a shipment of COVID vaccine that needed to be stored in the freezer. There was no room in the freezer to accommodate the shipment. The reporter was unaware that there were two Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), It was assumed that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) received could be refrigerated and were moved to the refrigerators where they remained within normal refrigerated temperature range (36 to 46 degrees Fahrenheit) until administration. The dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) administered to this patient arrived to the facility on 13-JAN-2025, and on 29-JAN-2025, the patient was vaccinated with this second dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection (lot# Y017208, expiration date was not reported, but upon internal validation established as 13-APR-2026; strength and dose were not reported) subcutaneously in the left arm for prophylaxis (product storage error) at a public health clinic. No additional adverse event (AE). This is one of several reports received from the same reporter.
IPOL; Boostrix; Menveo; Engerix-B; Sterile Diluent